(Q41722679)

English

Infrequent development of resistance in genotype 1-6 hepatitis C virus-infected subjects treated with sofosbuvir in phase 2 and 3 clinical trials.

scientific article published on 28 September 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25266287%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Infrequent development of resistance in genotype 1-6 hepatitis C virus-infected subjects treated with sofosbuvir in phase 2 and 3 clinical trials (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25266287%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

phase II clinical trial

0 references

0 references

Hepatitis C virus

1 reference

based on heuristic

inferred from title

Hadas Dvory-Sobol

2

object named as

Hadas Dvory-Sobol

0 references

16

object named as

David L Wyles

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25266287%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author name string

Evguenia S Svarovskaia

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25266287%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Hadas Dvory-Sobol

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25266287%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Neil Parkin

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25266287%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Christy Hebner

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25266287%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Viktoria Gontcharova

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25266287%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Ross Martin

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25266287%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Wen Ouyang

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25266287%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Bin Han

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25266287%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Simin Xu

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25266287%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Karin Ku

10

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25266287%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Sophia Chiu

11

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25266287%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Edward Gane

12

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25266287%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Ira M Jacobson

13

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25266287%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

David R Nelson

14

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25266287%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Eric Lawitz

15

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25266287%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Neby Bekele

17

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25266287%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Diana Brainard

18

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25266287%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

William T Symonds

19

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25266287%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

John G McHutchison

20

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25266287%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Michael D Miller

21

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25266287%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Hongmei Mo

22

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25266287%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

language of work or name

0 references

publication date

28 September 2014

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25266287%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25266287%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

59

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25266287%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

12

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25266287%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1666-1674

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25266287%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU697

21 January 2018

Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU697

21 January 2018

Hepatitis C virus: standard-of-care treatment

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU697

21 January 2018

Review of direct-acting antiviral agents for the treatment of chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU697

21 January 2018

Telaprevir for previously treated chronic HCV infection

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU697

21 January 2018

Telaprevir for previously untreated chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU697

21 January 2018

Boceprevir for untreated chronic HCV genotype 1 infection

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU697

21 January 2018

Boceprevir for previously treated chronic HCV genotype 1 infection

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU697

21 January 2018

Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trial

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU697

21 January 2018

Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU697

21 January 2018

Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU697

21 January 2018

Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU697

21 January 2018

Sofosbuvir for previously untreated chronic hepatitis C infection

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU697

21 January 2018

Current and future therapies for hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU697

21 January 2018

New hepatitis C virus (HCV) drugs and the hope for a cure: concepts in anti-HCV drug development

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU697

21 January 2018

Evolution of treatment-emergent resistant variants in telaprevir phase 3 clinical trials

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU697

21 January 2018

Genotypic and phenotypic analysis of variants resistant to hepatitis C virus nonstructural protein 5A replication complex inhibitor BMS-790052 in humans: in vitro and in vivo correlations.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU697

21 January 2018

Antiviral therapy of hepatitis C in 2014: do we need resistance testing?

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU697

21 January 2018

Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU697

21 January 2018

Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU697

21 January 2018

Genotype and subtype profiling of PSI-7977 as a nucleotide inhibitor of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU697

21 January 2018

Replication fitness and NS5B drug sensitivity of diverse hepatitis C virus isolates characterized by using a transient replication assay

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU697

21 January 2018

Characterization of resistance to non-obligate chain-terminating ribonucleoside analogs that inhibit hepatitis C virus replication in vitro

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU697

21 January 2018

Inhibition of hepatitis C replicon RNA synthesis by beta-D-2'-deoxy-2'-fluoro-2'-C-methylcytidine: a specific inhibitor of hepatitis C virus replication

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU697

21 January 2018

General Catalytic Deficiency of Hepatitis C Virus RNA Polymerase with an S282T Mutation and Mutually Exclusive Resistance towards 2'-Modified Nucleotide Analogues

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU697

21 January 2018

In vitro selected Con1 subgenomic replicons resistant to 2'-C-methyl-cytidine or to R1479 show lack of cross resistance

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU697

21 January 2018

Sofosbuvir (GS-7977) plus peginterferon/ribavirin in treatment-naïve patients with HCV genotype 1: a randomized, 28-day, dose-ranging trial

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU697

21 January 2018

Natural variation in drug susceptibility to HCV polymerase inhibitors in treatment-naïve HCV patient isolates

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU697

21 January 2018

In vivo emergence of a novel mutant L159F/L320F in the NS5B polymerase confers low-level resistance to the HCV polymerase inhibitors mericitabine and sofosbuvir

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU697

21 January 2018

Mechanistic characterization of GS-9190 (Tegobuvir), a novel nonnucleoside inhibitor of hepatitis C virus NS5B polymerase

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU697

21 January 2018

Activity of a Potent Hepatitis C Virus Polymerase Inhibitor in the Chimpanzee Model

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU697

21 January 2018

GT-1a or GT-1b Subtype-Specific Resistance Profiles for Hepatitis C Virus Inhibitors Telaprevir and HCV-796

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU697

21 January 2018

Natural polymorphisms associated with resistance to new antivirals against HCV in newly diagnosed HIV-HCV-coinfected patients

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU697

21 January 2018

Susceptibility of treatment-naive hepatitis C virus (HCV) clinical isolates to HCV protease inhibitors

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU697

21 January 2018

Characterization of Hepatitis C virus resistance from a multiple-dose clinical trial of the novel NS5A inhibitor GS-5885.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU697

21 January 2018

Antiviral activity of the new DAAs for the treatment of hepatitis C virus infection: virology and resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/25266287

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phylogeny and molecular evolution of the hepatitis C virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/25266287

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/CID/CIU697

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25266287%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25266287%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25266287%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41722679&oldid=2074841066"